chronic lymphocytic leukemia

Nanoscale “cages” made from strands of DNA can encapsulate small-molecule drugs and release them in response to a specific stimulus, McGill University researchers report in a new study. 

The research, published online Sept. 1 in Nature Chemistry, marks a step toward the use of biological nanostructures to deliver drugs to diseased cells in patients. The findings could also open up new possibilities for designing DNA-based nanomaterials.

Classified as: DNA, nanostructures, structural biology, Sleiman, Lady Davis, chronic lymphocytic leukemia, prostate cancer, Nanotechnology
Published on: 3 Sep 2013